NATCO PHARMA LTD FDA Approval ANDA 203007

ANDA 203007

NATCO PHARMA LTD

FDA Drug Application

Application #203007

Documents

Letter2020-10-30

Application Sponsors

ANDA 203007NATCO PHARMA LTD

Marketing Status

None (Tentative Approval)001

Application Products

001TABLET;ORAL250MG0LAPATINIBLAPATINIB

FDA Submissions

UNKNOWN; ORIG1TA2015-09-18

Submissions Property Types

ORIG1Null1

TE Codes

001PrescriptionAB

CDER Filings

NATCO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203007
            [companyName] => NATCO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"LAPATINIB","activeIngredients":"LAPATINIB","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/18\/2015","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2015-09-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.